Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
JOURNAL OF THORACIC ONCOLOGY
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
P2.03-04 Predicting Risk of Distant Brain Failure with Radiosurgery and Systemic Therapy in a Diverse NSCLC Brain Metastasis Population
. 18:s303.
2023
EP07.03-006 Feasibility of TTFields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Real-World Data
. 17:s332-s333.
2022
P19.06 Radiosurgery followed by Tumor Treating Fields for brain metastases (1-10) from NSCLC in the phase 3 METIS trial
. 16:s357.
2021
P2.01-63 Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial
. 14:s664.
2019
3PD Liquid biopsy in patients with adenocarcinoma of the lung and its correlation with their tumor tissue molecular profile
. 11:S58.
2016
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum-and erlotinib-resistant adenocarcinoma of the lung
. 5:1054-1059.
2010
Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer
. 5:533-539.
2010
Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer
. 3:511-515.
2008
P3-197: Risk of central nervous system bleeding in patients with brain metastases from non–small cell lung cancer (NSCLC) following whole brain radiation therapy (wbrt) is low
. 2:s764.
2007
Feasibility of TTFields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Real-World Data
2022
Genomic Evolution During TKI Treatment in Non-Small Cell Lung Cancer Patients With or Without Acquired T790M Mutation
2019
Tumor Treating Fields and Radiosurgery for Supra-and/or Infratentorial Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Study
2018
Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression
2017
METIS: A Phase 3 Study of Radiosurgery with TTFields for 1-10 Brain Metastases from NSCLC
2017
Report on Liquid Biopsies from Advanced Lung Adenocarcinoma Patients and Correlation with Their Tumor Biopsy Profiles
2017
"Real World" Use of Liquid Biopsy in Patients With Lung Adenocarcinoma and Correlation With Tumor Tissue Genetic Profile
2016
Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar
2016
Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar
2016
Genomic Analysis of Lung Cancer Tumors from Hispanic Patients Living in the US
2015
EXPLORING DISPARITIES IN HEALTH CARE OUTCOMES IN MINORITY POPULATIONS WITH SMALL (SCLC) AND NON-SMALL CELL LUNG CANCERS (NSCLC)
2013
MEMORY PRESERVATION WITH CONFORMAL AVOIDANCE OF THE HIPPOCAMPUS DURING WHOLE-BRAIN RADIOTHERAPY FOR PATIENTS WITH BRAIN METASTASES: PRELIMINARY RESULTS OF RTOG 0933
2013
PHASE I STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASES
2012
Sublobar Resection with Intraoperative 125I Brachytherapy vs Stereotactic Body Radiation Therapy for Treatment of Clinical Early Stage Non-Small Cell Lung Cancer in Patients not Eligible for Lobectomy
2012
PHASE 1 SAFETY AND PHARMACOKINETIC (PK) STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASES
2012
Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials
2007
Predictors of survival for non-small-cell lung cancer patients with brain metastases treated with whole brain radiation therapy: pooled data from two randomized trials
2007
Lung Cancer in Peru
2020
ROS-1 Rearrangements in Circulating Tumor Cells
2018
EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?
2018
Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping
2017
Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer
2006
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
2018
Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.
2023
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians.
2022
TGF-β Signaling Pathway in Lung Adenocarcinoma Invasion
2010
Research
category
ONCOLOGY
Category
RESPIRATORY SYSTEM
Category
Identifiers
International Standard Serial Number (ISSN)
1556-0864
Electronic International Standard Serial Number (EISSN)
1556-1380
Other
journal abbreviation
J THORAC ONCOL